IMTX — Immatics N.V. stock price, charts and financials

QT53Immatics N.V.

Immatics N.V. (NASDAQ: IMTX) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
8.62
-0.20-2.27%
OverviewShort InterestFilings
IMTXQT53Immatics N.V.·NASDAQ
8.62-2.27%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Aug 27, 20264Statement of changes in beneficial ownership
Aug 27, 2026SC 13D/ABeneficial ownership statement (active, amended)
Aug 26, 20266-KForeign issuer report
Aug 25, 2026424B2Prospectus
Aug 18, 20266-KForeign issuer report
Aug 18, 20264Statement of changes in beneficial ownership
Aug 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jul 29, 20263Initial statement of beneficial ownership
Jun 25, 2026S-8Registration of employee benefit securities
Jun 18, 20264Statement of changes in beneficial ownership
Jun 18, 20264Statement of changes in beneficial ownership
Jun 18, 20264Statement of changes in beneficial ownership
Jun 18, 20266-KForeign issuer report
Jun 18, 20264Statement of changes in beneficial ownership
Jun 18, 20264Statement of changes in beneficial ownership
Jun 18, 20264Statement of changes in beneficial ownership
Jun 18, 20264Statement of changes in beneficial ownership
Jun 18, 20264Statement of changes in beneficial ownership
Jun 18, 20264Statement of changes in beneficial ownership
Jun 02, 20266-KForeign issuer report
Jun 01, 20266-KForeign issuer report
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 15, 2026SC 13GBeneficial ownership statement (passive)
#1 / 25 of 190
Page
▼
/ 8